NGM BIOPHARMACEUTICALS INC Business Finance Contracts & Agreements
9 Contracts & Agreements
- Guaranty Agreements (1 contract)
- Investor Rights Agreements (1)
- Stock Agreements (4)
- Underwriting Agreements (2)
- Warrant Agreements (1)
- Limited Guaranty, dated February 25, 2024 (Filed With SEC on February 26, 2024)
- Underwriting Agreement, dated as of January 5, 2021, by and among NGM Biopharmaceuticals, Inc., Goldman Sachs & Co. LLC, Citigroup Global Markets Inc. and Cowen and Company, LLC (Filed With SEC on January 6, 2021)
- Description of Capital Stock (Filed With SEC on March 17, 2020)
- Form of Common Stock Certificate (Filed With SEC on April 1, 2019)
- 2019 Employee Stock Purchase Plan, to be in effect upon completion of this offering (Filed With SEC on March 25, 2019)
- Form of Common Stock Certificate (Filed With SEC on March 25, 2019)
- Form of Underwriting Agreement (Filed With SEC on March 25, 2019)
- Warrant to Purchase Stock, by and between NGM Biopharmaceuticals, Inc. and Silicon Valley Bank, dated February 3, 2009 (Filed With SEC on September 28, 2018)
- Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated March 20, 2015 (Filed With SEC on September 28, 2018)
